Enterococci are naturally tolerant to typically bactericidal cell wall-active antibiotics, meaning that their growth is inhibited but they are not killed even when exposed to a high concentration of the drug. The molecular reasons for this extraordinary tolerance are still incompletely understood. Previous work showed that resistance to killing collapsed specifically in mutants affected in superoxide dismutase (Sod) activity, arguing that bactericidal antibiotic treatment led to induction of a superoxide burst. In the present work, we show that loss of antibiotic tolerance in ⌬sodA mutants of pathogenic enterococci is dependent on the energy source present during antibiotic treatment. Hexoses induce greater killing than the pentose ribose, and no killing was observed with glycerol as the energy source. These results point to glycolytic reactions as crucial for antibiotic-mediated killing of ⌬sodA mutants. A transposon mutant library was constructed in Enterococcus faecalis ⌬sodA mutants and screened for restored tolerance of vancomycin. Partially restored tolerance was observed in mutants with transposon integrations into intergenic regions upstream of regulators implicated in arginine catabolism. In these mutants, the arginine deiminase operon was highly upregulated. A model for the action of cell wall-active antibiotics in tolerant and nontolerant bacteria is proposed.
IMPORTANCEAntibiotic tolerance is a serious clinical concern, since tolerant bacteria have considerably increased abilities to resist killing by bactericidal drugs. Using enterococci as models for highly antibiotic-tolerant pathogens, we showed that tolerance of these bacteria is linked to their superoxide dismutase (Sod), arguing that bactericidal antibiotics induce generation of reactive oxygen species inside cells. Wild-type strains are tolerant because they detoxify these deleterious molecules by the activity of Sod, whereas Sod-deficient strains are killed. This study showed that killing depends on the energy source present during treatment and that an increase in arginine catabolism partially restored tolerance of the Sod mutants. These results are used to propose a mode-of-action model of cell wall-active antibiotics in tolerant and nontolerant bacteria.
Even though enterococci are considered low-virulence pathogens, treatment of enterococcal infections is often difficult and lengthy. International guidelines for treatment of infective enterococcal endocarditis recommend 4 to 6 weeks of administration of penicillin or ampicillin plus an aminoglycoside, with a risk of acute renal failure due to the nephrotoxicity of the latter antibiotics (1-3). Enterococci, which are lactic acid bacteria and part of the human commensal flora, are naturally highly tolerant to antibiotics considered to be bactericidal such as penicillins and glycopeptides (4, 5). The mechanisms that allow these organisms to escape the lethal action of those drugs are still incompletely understood. On the basis of previous studies, it was suggested that the tolerance...